AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.
A multicenter, blinded study adds clinical evidence for ultrasound as a noninvasive approach to improving cellulite and skin laxity.
An open-access paper describes PIILIF, a hidden follicle-centered inflammatory pattern that may interfere with standard pattern hair loss treatments, even in normal-appearing scalp.
As GLP-1s grow in popularity, more Americans are rethinking weight loss in the new year.
rater8 has introduced AI Insights, a conversational AI feature within its raVE platform that allows healthcare practices to query and quickly extract actionable answers from their patient feedback data.